NASDAQ:SRTSSensus Healthcare Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Sensus Healthcare Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $3.00 0.00 (0.00 %) (As of 06/5/2020 04:00 PM ET) Add Compare Share Today's Range$2.98Now: $3.00▼$3.1950-Day Range$1.83MA: $2.39▼$3.0952-Week Range$1.76Now: $3.00▼$6.58Volume45,109 shsAverage Volume51,534 shsMarket Capitalization$49.53 millionP/E RatioN/ADividend YieldN/ABeta0.21 ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Sensus Healthcare, Inc. manufactures and markets superficial radiation therapy devices to healthcare providers worldwide. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sculptura product, a proprietary robotic intraoperative radiation therapy system that uses patented Beam Sculpting capabilities to treat various cancers during surgery; and Sentinel service program, which offers its customers protection for their systems. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons, eye shields, and disposable applicator tips, which are used to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was founded in 2010 and is headquartered in Boca Raton, Florida.Read More Beat the Market (BTM) Rank™ 4.3 Analyst's Opinion Consensus RatingSensus Healthcare has received a consensus rating of Buy. The company's average rating score is 2.60, and is based on 3 buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $4.21, Sensus Healthcare has a potential upside of 40.3% from its current price of $3.00.Amount of Analyst CoverageSensus Healthcare has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 2.6 Community Rank Outperform VotesSensus Healthcare has received 150 “outperform” votes. (Add your “outperform” vote.)Underperform VotesSensus Healthcare has received 138 “underperform” votes. (Add your “underperform” vote.)Community SentimentSensus Healthcare has received 52.08% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Sensus Healthcare and other stocks. Vote “Outperform” if you believe SRTS will outperform the S&P 500 over the long term. Vote “Underperform” if you believe SRTS will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldSensus Healthcare does not currently pay a dividend.Dividend GrowthSensus Healthcare does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Sensus Healthcare insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 29.90% of the stock of Sensus Healthcare is held by insiders.Percentage Held by InstitutionsOnly 9.20% of the stock of Sensus Healthcare is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Sensus Healthcare are expected to grow in the coming year, from ($0.59) to ($0.12) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Sensus Healthcare is -15.79, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Sensus Healthcare is -15.79, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSensus Healthcare has a P/B Ratio of 1.76. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 4.3Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.51 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SRTS Previous Symbol CUSIPN/A CIK1494891 Webwww.sensushealthcare.com Phone561-922-5808Debt Debt-to-Equity Ratio0.04 Current Ratio5.24 Quick Ratio4.54Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$27.26 million Price / Sales1.82 Cash FlowN/A Price / Cash FlowN/A Book Value$1.70 per share Price / Book1.76Profitability EPS (Most Recent Fiscal Year)($0.10) Net Income$-1,700,000.00 Net Margins-13.47% Return on Equity-11.86% Return on Assets-8.99%Miscellaneous Employees48 Outstanding Shares16,510,000Market Cap$49.53 million Next Earnings Date8/13/2020 (Estimated) OptionableNot Optionable NASDAQ:SRTS Rates by TradingView Receive SRTS News and Ratings via Email Sign-up to receive the latest news and ratings for SRTS and its competitors with MarketBeat's FREE daily newsletter. Sensus Healthcare (NASDAQ:SRTS) Frequently Asked Questions How has Sensus Healthcare's stock been impacted by COVID-19 (Coronavirus)? Sensus Healthcare's stock was trading at $3.25 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, SRTS shares have decreased by 7.7% and is now trading at $3.00. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Sensus Healthcare? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sensus Healthcare in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Sensus Healthcare. When is Sensus Healthcare's next earnings date? Sensus Healthcare is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for Sensus Healthcare. How were Sensus Healthcare's earnings last quarter? Sensus Healthcare Inc (NASDAQ:SRTS) issued its quarterly earnings data on Thursday, May, 7th. The company reported ($0.22) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.04) by $0.18. The business had revenue of $1.68 million for the quarter, compared to analyst estimates of $6.20 million. Sensus Healthcare had a negative net margin of 13.47% and a negative return on equity of 11.86%. View Sensus Healthcare's earnings history. What price target have analysts set for SRTS? 5 brokers have issued 12 month price targets for Sensus Healthcare's shares. Their forecasts range from $2.40 to $6.00. On average, they expect Sensus Healthcare's share price to reach $4.21 in the next year. This suggests a possible upside of 40.3% from the stock's current price. View analysts' price targets for Sensus Healthcare. Has Sensus Healthcare been receiving favorable news coverage? Media coverage about SRTS stock has been trending somewhat positive on Saturday, according to InfoTrie Sentiment. The research group scores the sentiment of media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Sensus Healthcare earned a news sentiment score of 0.5 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 3.0 out of 10, indicating that recent media coverage is unlikely to have an impact on the company's share price in the next few days. View the latest news aboutSensus Healthcare. Who are some of Sensus Healthcare's key competitors? Some companies that are related to Sensus Healthcare include TELA Bio (TELA), Soliton (SOLY), Pulse Biosciences (PLSE), RenovaCare (RCAR), Apyx Medical (APYX), T2 Biosystems (TTOO), Restoration Robotics (HAIR), BeyondAirInc . (XAIR), Venus Concept (VERO), Spectral Medical (EDTXF), PAVmed (PAVM), Titan Medical (TMDI), SANUWAVE Health (SNWV), AIT Therapeutics (AITB) and BRAINSWAY LTD/S (BWAY). View all competitors. What other stocks do shareholders of Sensus Healthcare own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sensus Healthcare investors own include Ring Energy (REI), Ring Energy (REI), Senseonics (SENS), Sangamo Therapeutics (SGMO), Sorrento Therapeutics (SRNE), Zynerba Pharmaceuticals (ZYNE), Aytu Bioscience (AYTU), Crispr Therapeutics (CRSP), Melinta Therapeutics (MLNT) and Nabriva Therapeutics (NBRV). Who are Sensus Healthcare's key executives? Sensus Healthcare's management team includes the following people: Mr. Joseph C. Sardano, Chairman, CEO & Pres (Age 66)Mr. Arthur R. Levine, Chief Financial Officer (Age 61)Mr. Kalman Fishman, COO & CTO (Age 48)Dr. Ziv Karni, Chief Scientific Officer (Age 74)Mr. Michael Sardano, VP, Gen. Counsel, Corp. Sec. and Director of Governance & Regulatory (Age 30) When did Sensus Healthcare IPO? (SRTS) raised $20 million in an initial public offering on Wednesday, March 30th 2016. The company issued 1,800,000 shares at $10.00-$12.00 per share. Joseph Gunnar and Feltl and Company served as the underwriters for the IPO and Neidiger, Tucker, Bruner was co-manager. What is Sensus Healthcare's stock symbol? Sensus Healthcare trades on the NASDAQ under the ticker symbol "SRTS." Who are Sensus Healthcare's major shareholders? Sensus Healthcare's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Rench Wealth Management Inc. (0.27%) and Morgan Stanley (0.08%). Company insiders that own Sensus Healthcare stock include Arthur Levine, Joseph C Sardano, Kalman Fishman, Richard Golin and Stephen Brad Cohen. View institutional ownership trends for Sensus Healthcare. Which institutional investors are buying Sensus Healthcare stock? SRTS stock was acquired by a variety of institutional investors in the last quarter, including Rench Wealth Management Inc., and Morgan Stanley. View insider buying and selling activity for Sensus Healthcare. How do I buy shares of Sensus Healthcare? Shares of SRTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Sensus Healthcare's stock price today? One share of SRTS stock can currently be purchased for approximately $3.00. How big of a company is Sensus Healthcare? Sensus Healthcare has a market capitalization of $49.53 million and generates $27.26 million in revenue each year. The company earns $-1,700,000.00 in net income (profit) each year or ($0.10) on an earnings per share basis. Sensus Healthcare employs 48 workers across the globe. What is Sensus Healthcare's official website? The official website for Sensus Healthcare is www.sensushealthcare.com. How can I contact Sensus Healthcare? Sensus Healthcare's mailing address is 851 BROKEN SOUND PARKWAY NW SUITE 215, BOCA RATON FL, 33487. The company can be reached via phone at 561-922-5808 or via email at [email protected] This page was last updated on 6/6/2020 by MarketBeat.com Staff
